03/08/2010 - Nature Medicine - The LRRK2 Biology Consortium, funded by MJFF to advance understanding of the LRRK2 gene, is profiled in the March edition of Nature Medicine.
03/08/2010 - Nature Medicine - Nature Medicine discusses the latest technology for creating improved pre-clinical research models, including models funded by MJFF.
03/05/2010 - Karolinska awards honorary doctorates to people who have not earned a PhD through formal academic achievements, but who have benefited research through other means.
03/05/2010 - The Vanderbilt Reporter - A Vanderbilt University study of deep brain stimulation for early Parkinson's disease has shown such promise that several other universities have signed on to plan a large-scale, multi-center trial.
03/04/2010 - The New York Times - New research suggests that Parkinson's disease may impair a person’s ability to read the emotions of others.
03/02/2010 - Researchers funded in part by MJFF have announced a vaccine that reverses an experimental form of PD in a pre-clinical model. MJFF spoke with Dr. David Standaert about what the news may mean for patients.
03/02/2010 - Two Challenges aim to streamline efforts focused on genetic targets alpha-synuclein and LRRK2. The third will drive collaborations that maximize the resources of the Brain & Body Donation Program at the Arizona Parkinson’s Disease Consortium.
MJFF is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today.
Read Progress, our 2008 Annual Report
Whether you flip pancakes, sell lemonade or run a marathon, you can be part of a team that has found countless ways to raise millions of dollars for The Michael J. Fox Foundation.
